
Significant fatigue at the start of cancer treatment is associated with a greater risk of severe side effects and shorter survival, a new study finds. Researchers analyzed data from four clinical trials of lung cancer or prostate cancer treatments that were conducted by the SWOG Cancer Research Network, a cancer clinical trials group funded by… read on > read on >